Latest Tuberculosis treatment Stories
A study published in the American Journal of Public Health finds links between mining and the spread of tuberculosis in sub-Saharan Africa.
According to a paper published today in the Lancet, there is unprecedented progress in the development of the global tuberculosis (TB) drug pipeline with 10 drug candidates currently in clinical development.
HIV-infected patients who are falsely diagnosed as having tuberculosis (TB) have higher rates of mortality than those who are correctly diagnosed with the disease.
NEW YORK and BANGALORE, India, May 3 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis (TB), including drug resistant strains of the disease.
HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc.
Two new tuberculosis studies by UT Southwestern Medical Center researchers provide good news and bad news about the bacterium that infects nearly a third of the world's population and a disease that kills nearly 2 million people each year.
American Lung Association in California Commemorates World TB Day by Supporting Efforts to Eradicate this Devastating Disease LOS ANGELES, March 24 /PRNewswire-USNewswire/ -- The following statement has been released by Jane Warner, President and CEO, American Lung Association in California: Tuberculosis (TB) continues to be a serious public health threat in the U.S.
WASHINGTON, March 23 /PRNewswire-USNewswire/ -- What: A Senate briefing, Bringing Established Methods to Scale: New Perspectives in the Changing World of TB, to discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively-drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world.
WASHINGTON, March 18 /PRNewswire/ -- Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis -- and replace an almost 50-year-old drug regimen.
When people get exposed to the mycobacterium responsible for tuberculosis (TB), some will become sick with a disease that is a major cause of mortality around the world while others simply don't.
- A woman chauffeur.
- A woman who operates an automobile.